215 related articles for article (PubMed ID: 12516101)
21. Postoperative survival of lung cancer patients: are there predictors beyond TNM?
Friedel G; Fritz P; Goletz S; Kristen R; Brinkmann F; Dierkesmann R; Schwab M; Ott G; Dippon J; Alscher MD
Anticancer Res; 2013 Apr; 33(4):1609-19. PubMed ID: 23564805
[TBL] [Abstract][Full Text] [Related]
22. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
Yung KC; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
[TBL] [Abstract][Full Text] [Related]
23. The impact of comorbidity upon determinants of outcome in patients with lung cancer.
Grose D; Morrison DS; Devereux G; Jones R; Sharma D; Selby C; Docherty K; McIntosh D; Nicolson M; McMillan DC; Milroy R;
Lung Cancer; 2015 Feb; 87(2):186-92. PubMed ID: 25498829
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a comorbidity scoring system for patients with cirrhosis.
Jepsen P; Vilstrup H; Lash TL
Gastroenterology; 2014 Jan; 146(1):147-56; quiz e15-6. PubMed ID: 24055278
[TBL] [Abstract][Full Text] [Related]
25. Hyponatraemia - evaluation of prevalence in patients hospitalized in the Pulmonary Department and prognostic significance in lung cancer patients.
Zarzecka M; Kubicki P; Kozielski J
Pneumonol Alergol Pol; 2014; 82(1):18-24. PubMed ID: 24391067
[TBL] [Abstract][Full Text] [Related]
26. Clinical course of lung cancer in patients with chronic kidney disease.
Patel P; Henry LL; Ganti AK; Potti A
Lung Cancer; 2004 Mar; 43(3):297-300. PubMed ID: 15165087
[TBL] [Abstract][Full Text] [Related]
27. Comparing a medical records-based and a claims-based index for measuring comorbidity in patients with lung or colon cancer.
Kehl KL; Lamont EB; McNeil BJ; Bozeman SR; Kelley MJ; Keating NL
J Geriatr Oncol; 2015 May; 6(3):202-10. PubMed ID: 25662785
[TBL] [Abstract][Full Text] [Related]
28. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.
Lee PC; Nasar A; Port JL; Paul S; Stiles B; Chiu YL; Andrews WG; Altorki NK
Ann Thorac Surg; 2013 Sep; 96(3):951-60; discussion 960-1. PubMed ID: 23866808
[TBL] [Abstract][Full Text] [Related]
29. Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged > 80 years.
Breen D; Barlési F; Zemerli M; Doddoli C; Torre JP; Thomas P; Astoul P
Clin Lung Cancer; 2007 Mar; 8(5):331-4. PubMed ID: 17562233
[TBL] [Abstract][Full Text] [Related]
30. Impact on survival of modelling increased surgical resection rates in patients with non-small-cell lung cancer and cardiovascular comorbidities: a VICORI study.
Welch CA; Sweeting MJ; Lambert PC; Rutherford MJ; Jack RH; West D; Adlam D; Peake M
Br J Cancer; 2020 Aug; 123(3):471-479. PubMed ID: 32390010
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic percutaneous transthoracic needle biopsy does not affect survival in stage I lung cancer.
Wisnivesky JP; Henschke CI; Yankelevitz DF
Am J Respir Crit Care Med; 2006 Sep; 174(6):684-8. PubMed ID: 16799079
[TBL] [Abstract][Full Text] [Related]
32. [Bronchial cancer--development, diagnosis, therapy, prognosis].
Zöchbauer S; Krajnik G; Huber H
Wien Klin Wochenschr; 1994; 106(14):431-47. PubMed ID: 7941590
[TBL] [Abstract][Full Text] [Related]
33. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
34. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.
Cerfolio RJ; Bryant AS; Scott E; Sharma M; Robert F; Spencer SA; Garver RI
Chest; 2006 Dec; 130(6):1796-802. PubMed ID: 17166999
[TBL] [Abstract][Full Text] [Related]
35. Comorbidity and Survival in Lung Cancer Patients.
Islam KM; Jiang X; Anggondowati T; Lin G; Ganti AK
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1079-85. PubMed ID: 26065838
[TBL] [Abstract][Full Text] [Related]
36. Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer.
Mellemgaard A; Lüchtenborg M; Iachina M; Jakobsen E; Green A; Krasnik M; Møller H
J Thorac Oncol; 2015 Feb; 10(2):272-9. PubMed ID: 25371078
[TBL] [Abstract][Full Text] [Related]
37. Prediction of acute toxicity grade ≥ 3 in patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin.
Uyterlinde W; Belderbos J; Baas C; van Werkhoven E; Knegjens J; Baas P; Smit A; Rikers C; van den Heuvel M
Clin Lung Cancer; 2013 Sep; 14(5):541-8. PubMed ID: 23835165
[TBL] [Abstract][Full Text] [Related]
38. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status.
Baser S; Shannon VR; Eapen GA; Jimenez CA; Onn A; Lin E; Morice RC
Chest; 2006 Dec; 130(6):1784-90. PubMed ID: 17166997
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
[TBL] [Abstract][Full Text] [Related]
40. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study.
Lund L; Jacobsen J; Nørgaard M; McLaughlin JK; Blot WJ; Borre M; Sørensen HT
J Urol; 2009 Jul; 182(1):35-40; discussion 40. PubMed ID: 19450859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
